(NasdaqGM:COOT),(NasdaqGM:COOTW), COOTAMUNDRA, Australia, Oct. 30, 2025 (GLOBE NEWSWIRE) — Australian Oilseeds Holdings Limited (the “Company”) (NASDAQ: COOT), a manufacturer and seller of sustainable edible oils to customers globally, today announced it has received written notice from The Nasdaq Stock Market (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement […]

Rockville, Maryland, Oct. 30, 2025 (GLOBE NEWSWIRE) — Consumers are cautiously optimistic about health insurers' use of artificial intelligence (AI), with most saying they would support it if it leads to faster care decisions and maintains a strong human role, according to a new survey commissioned by Zyter|TruCare. The national poll of 600 insured adults

(NASDAQ:RUN), SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) — Sunrun (Nasdaq: RUN), America's largest provider of home battery storage, solar, and home-to-grid power plants, today released new national survey data revealing that rising energy demand from AI and data centers, coupled with worsening extreme weather, is deepening homeowners' anxiety about the reliability and affordability of

ST. LOUIS, Oct. 30, 2025 (GLOBE NEWSWIRE) — MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, today announced that data from the Company's transdermal GFR technology has been accepted for an oral presentation at the upcoming American Society of Nephrology (ASN) Kidney Week 2025 in

(NASDAQ:PDSB), Three abstracts accepted for presentation, including one rapid oral abstract session Presentations to highlight ongoing clinical and translational research across PDS Biotechnology's immunotherapy platforms PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets

(NASDAQ:VERU), MIAMI, FL, Oct. 30, 2025 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, announced today the pricing of an underwritten public offering of (i) 1,400,000 shares of its common stock, (ii) pre-funded warrants to purchase up

(NASDAQ:BCDA), SUNNYVALE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the first patient enrolled at University of Wisconsin School of Medicine and Public Health in its ongoing Phase 3 CardiAMP HF II clinical trial.

(NASDAQ:XWEL), NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) — XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), a leading provider of wellness solutions for people on the go, today announced its partnership with Priority Pass, the world's leading airport experiences program, is going global. What first launched in North America last year is now being

(NASDAQ:ARQT), Once-daily, effective, safe, and well-tolerated ZORYVE cream 0.05% now commercially available for children as young as age 2 ZORYVE cream 0.05% provides rapid clearance of atopic dermatitis ZORYVE can be used anywhere on the body for any duration and is not a steroid Atopic dermatitis is the most common type of eczema, affecting approximately

(TSX-V:SGO),(OTC US:SMOFF),(Other OTC:SMOFF),(Boerse Frankfurt – Freiverkehr:23SP.F),(Boerse Frankfurt – Freiverkehr:23SP), VANCOUVER, Canada, Oct. 30, 2025 (GLOBE NEWSWIRE) — Sonoro Gold Corp. (TSXV: SGO | OTCQB: SMOFF | FRA: 23SP) (“Sonoro” or the “Company”) is pleased to announce the Company has made the final concession payment on its flagship Cerro Caliche gold project in Sonora, Mexico. In